Transarterial drug delivery for liver cancer: numerical simulations and experimental validation of particle distribution in patient-specific livers.

: Transarterial therapies are routinely used for the locoregional treatment of unresectable hepatocellular carcinoma (HCC). However, the impact of clinical parameters (i.e.